Los Angeles Biosciences
Playa Del Rey, US · Founded 2024 · Delaware corporation
Founders & leadership
JN
Jeff NicholsExecutive
DL
Derya L. KelterinExecutive
Board
KP
Ketan PatelBoard director
Reported raises · per SEC filings
Form D private placements$4.9M disclosed across 1 round · 2025
▶$4.9MraisedJun 2025 · 17 investors · Other Health CareRule 506(b)
▶$4.9MraisedJun 2025 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeff NicholsExecutive Officer
- Derya L. KelterExecutive Officer, Director
- Ketan PatelDirector
- Offering amount
- $5M
- Amount sold
- $4.9M
- Proceeds to insiders
- $1M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Los Angeles Biosciences raised?
- Los Angeles Biosciences has disclosed $4.9M raised across 1 round.
- Where is Los Angeles Biosciences headquartered?
- Los Angeles Biosciences is headquartered in Playa Del Rey, US.